Optimizing the Management of Age-Related Macular Degeneration and Diabetic Macular Edema: Evidence-Based Patient Case Review

Optimizing the Management of Age-Related Macular Degeneration and Diabetic Macular Edema: Evidence-Based Patient Case Review is organized by Pharmacy Times Continuing Education (PTCE).,Release date: August 17, 2022,Expiration date: August 17, 2023,Description:,Several pathways are involved in the destabilization and inflammation associated with reduced retinal function in neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Despite advances in anti-vascular endothelial growth factor therapy, as monotherapy, it does not address underlying inflammation or fibrosis. The expert panelists guiding this discussion will explore recent clinical data and the impact of combination therapies as well as novel delivery methods aimed to decrease the burden of blindness associated with nAMD and DME. Experts will share insights and strategies pharmacists can employ to reduce the significant economic burden of anti-vascular endothelial growth factor therapies for patients with nAMD and DME. Patient cases will be reviewed throughout the program to highlight best practices for pharmacists to promote adherence and provide patient-centered care.,Educational Objectives:,At the completion of this activity, participants will be able to:,• Analyze outcomes and evidence for use of anti-vascular endothelial growth factor therapies for the treatment of age-related macular degeneration (AMD) and diabetic macular edema (DME) through patient case reviews,• Examine how the treatment paradigm for AMD and DME has evolved and improved patient quality of life,• Identify the importance of the pharmacist in patient-centered care and shared decision-making in AMD and DME,• Explain best practices in the management of AMD and DME